- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02192801
Kidney Function in Patients With Bladder Exstrophy
July 16, 2014 updated by: Tel-Aviv Sourasky Medical Center
Evaluation of Long-term Renal Function in Patients After Surgical Repair of Classical Bladder Exstrophy
Patients with classical bladder exstrophy undergo many surgical interventions with secondary urinary tract infections complicating their course.
lately primary definitive surgical correction of this congenital anomaly has been implemented with satisfactory results.
Although bladder exstrophy patients are born with normal kidneys, infectious and mechanical surgical complications can potentially damage their kidneys in the long-term.
therefore we decided to evaluate renal function in the long-term in these patients.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Roxana Cleper, MD
- Phone Number: 972-3-6972512
- Email: roxanac@tlvmc.gov.il
Study Contact Backup
- Name: Jacob Ben Chaim, MD
- Email: jacobbc@tlvmc.gov.il
Study Locations
-
-
-
Tel Aviv, Israel
- Pediatric Outpatient Clinic Dana Children Hospital Tel Aviv Sourasky medical center
-
Principal Investigator:
- Jacob Ben Chaim, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 months to 28 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with calssic bladder exstrophy
Description
Inclusion Criteria:
- All patients with classic bladder exstrophy treated and followed in Pediatric urology clinic in Dana Children Hospital and Outpatient Clinic
Exclusion Criteria:
- No
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Renal function
Time Frame: 1 day (last visit )
|
Creatinine and GFR estimation , proteinuria, albuminuria will be assessed as measures of renal function as well as renal mass estimation through renal size as by ultrasound and in certain cases through dimercaptosucicnic acid (DMSA)renal scan
|
1 day (last visit )
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Anticipated)
April 1, 2016
Study Registration Dates
First Submitted
January 30, 2014
First Submitted That Met QC Criteria
July 16, 2014
First Posted (Estimate)
July 17, 2014
Study Record Updates
Last Update Posted (Estimate)
July 17, 2014
Last Update Submitted That Met QC Criteria
July 16, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TASMC-13-RC-0022-13-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proteinuria
-
Universiteit AntwerpenCompleted
-
University of Sao PauloCompleted
-
Nantes University HospitalTerminated
-
Marshall UniversityUniversity at BuffaloRecruiting
-
Greater Boston Medical AssociatesMassachusetts General HospitalUnknownDecrease of Proteinuria With H.P. Acthar Gel and Its Effects on Clinical and Podocyte FunctionUnited States
-
Gulhane School of MedicineCompletedWe Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.Turkey
-
University of Mississippi Medical CenterCompletedPregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia) | Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe) | Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia)United States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownBasal Proteinuria in PregnancyTurkey
-
Brigham and Women's HospitalBristol-Myers SquibbCompleted
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown